Jefferies Remains a Buy on AstraZeneca (AZN)

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Jefferies analyst Michael Leuchten maintained a Buy rating on AstraZeneca today and set a price target of £175.00.

According to TipRanks, Leuchten is an analyst with an average return of -3.1% and a 54.65% success rate. Leuchten covers the Healthcare sector, focusing on stocks such as AstraZeneca, GlaxoSmithKline, and Roche Holding AG.

In addition to Jefferies, AstraZeneca also received a Buy from Bernstein’s Justin Smith in a report issued on November 3. However, on November 6, Deutsche Bank maintained a Hold rating on AstraZeneca (LSE: AZN).

Source: Tip Ranks The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.